"Item","Total","Cards","PCPs","Nephs","Endos","Lipids","Physician","NP/PA","Higher","Lower","Tier 1","Tier 2","Tier 3","Tier 4","Segment A","Segment B","Segment C","Segment D","Priority Account","Non-Priority Account"
"Leqvio (inclisiran)","61% (110)","57% (68)","72% (38)","0% (0)","40% (2)","100% (2)","60% (90)","83% (10)","59% (54)","63% (56)","67% (29)","61% (51)","52% (24)","75% (6)","64% (36)","57% (21)","69% (25)","55% (27)","60% (80)","64% (30)"
"Praluent (alirocumab)","63% (113)","62% (74)","64% (34)","0% (0)","60% (3)","100% (2)","63% (94)","75% (9)","63% (57)","63% (56)","70% (30)","58% (48)","61% (28)","88% (7)","66% (37)","54% (20)","64% (23)","65% (32)","59% (79)","72% (34)"
"Repatha (evolocumab)","63% (114)","60% (72)","70% (37)","0% (0)","60% (3)","100% (2)","63% (95)","75% (9)","64% (58)","63% (56)","67% (29)","63% (52)","57% (26)","88% (7)","64% (36)","54% (20)","72% (26)","63% (31)","59% (79)","74% (35)"
"Nexletol (bempedoic acid) or Nexlizet (bempedoic acid and ezetimibe)","60% (108)","56% (67)","64% (34)","0% (0)","100% (5)","100% (2)","59% (88)","75% (9)","59% (54)","61% (54)","67% (29)","57% (47)","63% (29)","38% (3)","61% (34)","59% (22)","61% (22)","59% (29)","59% (78)","64% (30)"
